http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104370827-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42 |
| filingDate | 2013-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104370827-B |
| titleOfInvention | Rosuvastatin calcium compound |
| abstract | The invention belongs to pharmaceutical technology field, it is specifically related to Rosuvastatin hydrate of calcium and preparation method thereof, the Rosuvastatin hydrate of calcium that the present invention obtains, containing a hypocrystalline water, have the advantage that: purity is high, good stability, the invention still further relates to use Rosuvastatin hydrate of calcium manufacture treatment primary hypercholesterolemia or the application of Combination dyslipidaemia medicine. |
| priorityDate | 2013-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.